Skip to main content

Management of Infections of Devices: Catheter-Related Infections, Pretransplant VAD Infections, Infections of ECMO Devices

  • Chapter
  • First Online:
Infectious Diseases in Solid-Organ Transplant Recipients

Abstract

For the purposes of this chapter, we will discuss the management of infections of devices used in solid organ transplant (SOT). Post transplantation, SOT recipients frequently require additional interventions including central venous access catheters (CVC) or, occasionally, temporary support with extracorporeal membrane oxygenation (ECMO) intervention. Infections in these devices will be addressed. Furthermore, we will review infections associated with ventricular assist devices (VAD) when used as bridges to heart transplant (HT). Infection remains a significant complication of LVAD implantation and is associated with inferior clinical prognosis. This is especially true in patients who develop more serious systemic infections, such as sepsis, where the mortality in the following 2 years can be greater than 50%. Furthermore, the development of multi-organ dysfunction (especially cardiac and renal) is also frequently seen as sequelae of infection and complicates morbidity and mortality considerably. The ongoing management of mechanical circulatory device (MCS) infections in patients who proceed to transplant will also be discussed in this chapter, as these patients suffer more frequent relapse associated with retained material from their infected device.

CVC, ECMO, and VAD infections all share features that create unique infection risk, in that they all contain a foreign material placed with a percutaneous exit site and an internal, intravascular component.

Signs and symptoms of systemic device-associated infection may be subdued in the SOT recipient. The differential for potential pathogens may be broader in the immunocompromised postoperative host, not only because of their immunosuppression but also because of their frequent hospital exposure. Furthermore, the HT who was bridged with an initially infected VAD has a potentially increased risk for multidrug-resistant (MDR) infections due to antibiotic exposures, though this has not been well studied or documented in the current literature. Diagnosis and management of these infections will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Aubron C, Cheng A, Picher D, et al. Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcomes. Infect Control Hosp Epidemiol. 2013;34(1):24–30.

    Article  Google Scholar 

  2. Bizzaro M, Conrad S, Kaufman D, et al. Infections acquired during extracorporeal membrane oxygenation in neonates, children and adults. Pediatr Crit Care Med. 2011;12:277–81.

    Article  Google Scholar 

  3. Aubron C, Pilcher D, Leong T, et al. Aspergillus sp. Isolated in critically ill patients with extracorporeal membrane oxygenation support. Scand J Infect Dis. 2013;45(9):715–21.

    Article  Google Scholar 

  4. Garcia X, Mian A, Mendiratta P, et al. Aspergillus infection and extracorporeal membrane oxygenation support. J Intensive Care Med. 2013;28(3):178–84.

    Article  Google Scholar 

  5. Hannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections I patients using ventricular assist devices. J Heart Lung Transplant. 2011;30:375–84.

    Article  Google Scholar 

  6. Nienaber J, Wilhelm MP, Sohail MR. Current concepts in the diagnosis and management of left ventricular assist device infections. Expert Rev Anti Infect Ther. 2013;11(2):201–10.

    Article  CAS  Google Scholar 

  7. Kusne S, Mooney M, Danziger-Isacov L, et al. An ISHLT consensus document for preventions and management strategies for mechanical circulatory support infections. J Heart Lung Transplant. 2017;36:1137–53.

    Article  Google Scholar 

  8. Maly J, Szarszoi O, Netuka I, et al. Fungal infections associated with long-term mechanical circulatory support-diagnosis and management. J Card Surg. 2014;29:95–100.

    Article  Google Scholar 

  9. Baker A, Lewis S, Alexander B, et al. Two-phase hospital-associated outbreak of Mycobacterium abscessus: investigation and mitigation. Clin Infect Dis. 2017;64(7):902–11.

    PubMed  PubMed Central  Google Scholar 

  10. Balsam L, Louie E, Hill F, et al. Mycobacterium chimaera left ventricular assist device infections. J Card Surg. 2017;32(6):402–4.

    Article  Google Scholar 

  11. Juneau D, Golfam M, Hazra S, et al. Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2017;10:e005772.

    Article  Google Scholar 

  12. Holek M, Kettner J, Franeková J, Jabor A. Procalcitonin levels in patients undergoing left ventricular assist device implantation. Crit Care. 2015;19(Suppl 1):P61.

    Article  Google Scholar 

  13. Brown M, Bishburg E, Nagarakanti S, Divita M. The role of procalcitonin in the diagnosis of bacterial infections in patients with cardiac devices and orthotopic heart transplant. Open Forum Infect Dis. 2015;2(Suppl_1):245.

    Article  Google Scholar 

  14. Association for Prevention of Infection Control and Epidemiology—Guide to Preventing Central Line Bloodstream Infections. Accessed 15 Oct 2017. https://apic.org/Resources/Topic-specific-infection-prevention/Central-line-associated-bloodstream-infections.

  15. ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support Extracorporeal Life Support Organization, Version 1.4 August 2017 Ann Arbor, MI, USA. www.elso.org.

  16. Zakhour R, Chaftari A, Raad I. Catheter-related infections in patients with haematological malignancies: novel preventive and therapeutic strategies. Lancet Infect Dis. 2016;16(11):e241–50.

    Article  Google Scholar 

  17. McGhee W, Michaels M, Martin J, et al. Antifungal lock therapy with liposomal amphotericin B: a prospective trial. J Pediatric Infect Dis Soc. 2016;5(1):80–4.

    Article  Google Scholar 

  18. Wolf J, Connell T, Allison K, et al. Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial. Lancet Infect Dis. 2018;18:854–63.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cameron R. Wolfe .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wolfe, C.R., Mooney, M.L. (2019). Management of Infections of Devices: Catheter-Related Infections, Pretransplant VAD Infections, Infections of ECMO Devices. In: Manuel, O., Ison, M. (eds) Infectious Diseases in Solid-Organ Transplant Recipients. Springer, Cham. https://doi.org/10.1007/978-3-030-15394-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-15394-6_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-15393-9

  • Online ISBN: 978-3-030-15394-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics